I thank the witnesses for the presentation. It's very helpful to the committee to hear what you're up to now, but I would love to know what you think should happen.
Dreaming in technicolor, if you had the best possible data in order to do post-market surveillance in a real-world way, what would that system look like? I understand that we haven't yet asked Infoway to come, but I believe that post-market surveillance can be Canada's present to the world, and that we could figure out a way to do things better because of our single-payer system.
At the moment, what I'm hearing is that CIHI is still getting only billing data and provincial drug program data. You're not getting data from long-term care institutions. Is that right? You're not getting hospital data, and you're not getting diagnoses. So you don't know why it was prescribed, and you don't get a notice if someone changes from this medication to that medication. Can you track that or not?